Close Menu

NEW YORK (GenomeWeb) – Foundation Medicine and H3 Biomedicine have signed a multi-year collaboration to use genomic data to discover and develop oncology therapeutics, the companies said today.

The partnership marries Foundation Medicine's FoundationCORE, a genomic knowledgebase of more than 35,000 genomic profiles, with H3's drug discovery engine and computational biology platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.